uniQure announces ordinary share, warrant offering, no amount given
Qure (QURE) announced that it has commenced an underwritten public offering of its ordinary shares and pre-funded warrants to purchase its ...
uniQure Announces Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
BiolineRx Announces Major Direct Offering to Bolster Operations
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the closing of its ...
uniQure Inc.: uniQure Announces Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...